EVALUTION OF ANTI-DIABETIC ACTIVITY OF METHANOL EXTRACT OF DIGERA MURICATA (L) MART IN ALLOXAN INDUCED DIABETIC RATS
HTML Full TextEVALUTION OF ANTI-DIABETIC ACTIVITY OF METHANOL EXTRACT OF DIGERA MURICATA (L) MART IN ALLOXAN INDUCED DIABETIC RATS
- Jagatha* and N. Senthilkumar
Department of Pharmaceutical Chemistry, JKKMMRF College of Pharmacy, B. Komarapalayam, Namakkal (dt), Tamil Nadu, India
ABSTRACT
Digera muricata (L.) Mart (Amaranthaceae) commonly known as Cancali soppu widely used in traditional system of medicine for the treatment of diabetes mellitus In the present study, Methanol extract of Digera muricata(MEDM) leaves were subjected to phytochemical investigation and evaluated for antidiabetic activity in alloxan induced diabetic rats. MEDM (100, 200 mg/kg) and Glibenclamide (3mg/kg) were administered orally in alloxan (140 mg/kg, i.p.) induced diabetic rats. In acute oral toxicity (OECD Guide line 423) study, administration of MEDM no mortality upto 2000 mg/kg was observed. OGTT, Fasting blood glucose level, body weight, lipid profiles, HbA1c, plasma insulin, and ALP were evaluated in normal and diabetic rats. preliminary phytochemical investigation revealed the presence of alkaloids, flavonoids, glycosides, tannins as the major constituents in the methanol extract .These results suggest that MEDM (200mg/kg) showed antihyperglycemic activity in alloxan induced diabetic rats.
Keywords:Digera muricata ,
Alloxan, Glibenclamide, |
Antidiabetic activity
INTRODUCTION: Diabetes mellitus is a metabolic disorder characterized by hyperglycemia, abnormal lipid and protein metabolism along with specific long-term complications affecting the retina, kidney and nervoussystem 1. Hyperglycemia is an important factor in thedevelopment and progression of the complications of diabetes mellitus 2 Regions with greatest potential are Asia and Africa, where DM rates could rise to two-to-three- folds compared with the present rates. Apart from currently available therapeutic options, many herbal medicines have been recommended for the treatment of diabetes. Traditional plant medicines are used throughout the world for a range of diabetic presentation. Digera muricata(L) Mart is a Amaranthaceae Family .It is commonly distributed throughout the India. In Ayurveda the herb is considered as a cooling, astringent to the bowls and also used as laxative. The flowers and seeds are used to treat Urinary discharges 3.
The Digera muricata treatment augments the antioxidants defence mechanism against carbon tetrachloride induced toxicity and free radical mediated diseases. Annual herbs 30-60cm height branches glabrous spreading leaves 2-7.5 by 1.3-4.5cm variable, alternate, entire petiolate with angular branches. The reported studies of Digera muricata are Antimicrobial 4 protective effect 5 carbon tetra chloride nephrotoxicity 6, 7. The present study was conducted to investigate the Antidiabetic activity of methanolic extract of Abrus precatorius in Alloxan induced diabetic rats.
MATERIALS AND METHODS:
Plant collection and Authentication: The Leaves of Digera muricata collected from the outer area of Vellore district, Tamil Nadu. The collected plants were authenticated by Mr. Jayaraman, Director, National Institute of N. Herbal Science Tamil Nadu. (No.- PARC/2010/233).
Preparation of extract: The leaves Digera muricata were dried under shade and then made into a coarse powder andt he powder of Abrus precatorius (520g) was extracted with methanol by Soxhlet extraction for 48hrs. The extracts were concentrated to dryness. It gives a thick greenish semisolid residue. These extract was suspended in distilled water and used for further studies. The extracts were stored in an air tight container for further use.
Animals: Male albino-Wistar rats weighing 150-250g were used in the present study. All rats were kept at room temperature of 25±2oC in the animal house. All the procedures were followed the internationally accepted ethical guidelines for the care of laboratory animals. Prior to the experiments, rats were fed with standard food for one week in order to adapt to the laboratory condition, JKKMMRF College of Pharmacy. All the animals were followed the internationally accepted ethical guidelines for the care of laboratory animals (IAEC/2010/005).
Acute Toxicity Study: The procedure was followed as per (OECD 423 Acute classic method). The methanolic extract was tested for its acute toxicity in mice. To determine acute toxicity of methanolic extract of Digera muricata in different doses (100, 200mg/kg) were administered to different groups of mice and observed for signs of behavioral and mortality for 72hrs 8.
Oral Glucose Tolerance Test (OGTT): The overnight fasted (18 hr) normal rats were divided into four groups and each group consists of six animals. They were provided with drinking water only. Normal saline solution was administered to group I animals. Digera muricata methanol extract (100 mg/kg and 200 mg/kg) was administered, by oral route, to group II and III. Group IV animals were received Glibenclamide (3 mg/kg, b.w.) as a standard. Glucose (2g/kg) load was fed 30 minutes after the administration of dose.
Blood was withdrawn from tail vein under mild ether anesthesia at initial, and 30,60, 90 minutes after glucose (glucose load, 2g/kg) administration and glucose levels were estimated using glucose strips and a glucometer (Standard diagnostics Ltd). Blood glucose levels were noted and reported
Induction of Experimental Diabetes: Diabetes is to be induced in overnight fasted adult Wistar albino rats weighing 150-250 gm by single i.p. injection of 140 mg/kg Alloxan monohydrate (9). Alloxan monohydrate was dissolved in normal saline (pH 4.5). Animals were fed with 5% glucose solution in order to prevent hypoglycemic shock for 18 hrs Hyperglycemia is to be confirmed by elevated blood glucose levels in plasma, determined at 72 hrs and then on day 0 after injection. The threshold value of fasting plasma glucose to diagnose diabetes was taken as >200mg/dL. Only the rats found with permanent diabetes were used for the antidiabetic study.
Experimental Design: Experimental rats were divided into five groups of six animals each and treated for 21 days as follows.
Group I: Normal control rats fed with vehicles only
Group II: Diabetic controls rats (Alloxan monohydrate 140 mg/kg body weight of rats, once i.p injection)
Group III: Normal rats treated with methanolic extract of Digera muricata, 100mg/kg, per oral, 0.5% in carboxy methyl cellulose (CMC).
Group IV: Diabetic rats treated with methanolic extract of Digera muricata 200mg/kg, per oral, 0.5% in carboxy methyl cellulose (CMC)
Group V: Diabetic rats treated with standard drug, Glibenclamide 3mg/kg body weight in 0.5% carboxy methyl cellulose (CMC).
Sample Collection: Blood sample was collected at weekly intervals from tail vein puncture till the end of study. In the Continuous 21 days of drug treatment, a blood glucose level of all animals was determined at the 0, 7, 14, 21 day. On day 21, blood was collected by cardiac puncture under mild ether anesthesia from over night fasted rats. Blood was collected in tubes containing potassium oxalate and sodium fluoride as anticoagulant for estimation of fasting plasma glucose. Plasma and serum were separated by centrifuged at 4,000 rpm for 10 minutes; the clear supernatant was used for the analysis of various biochemical parameters 10, 11, 12.
Evaluation of Biochemical parameters: After 21 days of treatment, over night fasted rats were sacrificed and blood was collected from retro-orbital plexus using micro capillary technique and serum was separated. The biochemical estimation of serum Triglycerides, total Cholesterol, HDL Cholesterol, LDL Cholesterol, VLDL Cholesterol, HbA1C ALP were estimated by using a commercial kit from Med source Ozone Biomedical Pvt. Ltd 13.
Statistical analysis: Values are given as mean ±SEM and were compared using one way ANOVA with Tukey-Kramer multiple comparison test. The values of p<0.05 were considered statistically significant.
RESULT AND DISCUSSION: The present study was under taken to investigate the Antidiabetic activity of methanolic extract of Digera muricata (Martt) in Alloxan induced diabetic rats In The phytochemical analysis of Digera muricata leaves extracts were shown in table 1. OGTT, the doses of Methanol extract of Digera muricata (100mg/kg, 200mg/kg) increased the tolerance for glucose suggesting increased peripheral utilization of glucose MEDM at dose, 200 mg/kg possessed significant (p<0.01) reduction on blood glucose level when compared to MEDM at dose of 100 mg/kg. Hence, the reduction in blood glucose level was dose dependent shown in table 2 and figure 3.
Vehicles control animals were found to be stable in their body weight but significant reduction in diabetic control group during 21 days. Alloxan caused body weight reduction, which is slightly reversed by Methanol extract of Digera muricata treated (100mg/kg – 200mg/kg) groups after 21 days, but no significant reduction was noted in lower doses (100 mg/kg). While, significant (p<0.01) increase in body weight was observed in normal rats treated with methanol extract of Digera muricata. Hence, this extract caused increase in body weight of normal group. Glibenclamide to diabetic rats slightly decreased the body weight level are showed in table 4.
Treatment with MEDM at doses of 100mg/kg and 200mg/kg significantly decreased the blood glucose level in 21st day shown in table 5 and figure 4 and plasma insulin, glycosylated hemoglobin results are shown in table 7.
The serum lipid values of TC, TG, HDL, LDL and VLDL of those were treated with MEDM extract returned to values near to control group. The level of cholesterol and triglyceride increased in diabetic animals when compared to control animals. After MEDM treatment, the higher level of both cholesterol and triglyceride were restored towards the normal. The level of HDL in serum of diabetic animals was decreased. These lowered levels of HDL-cholesterol were restored significantly near to normal in MEDM treated diabetic groups. This showed that treatment with MEDM (200 mg/kg) significantly improved the lipid profile in Alloxan induced diabetic rats shown in table 8.
Serum alkaline phosphatase (ALP) level was increased in diabetic control group but this level was decreased significantly (p<0.01) in methanol extract of Digera muricata- treated groups ( 100, 200 mg/kg) and in normal rats treated with Digera muricata extract (Group III) due to 21 days of treatment. Normal ALP level was observed in normal control group (Group I). Hence, the methanol extract of Digera muricata possessed significant (p<0.01) effect on Serum alkaline phosphatase level shown in table 9.
TABLE 1: QUALITATIVE PHYTOCHEMICAL ANALYSIS OF DIGERA MURICATA LEAVES
Test | Pet. Ether extract | Methanol Extract | Aqueous Extract |
Carbohydrates | - | + | + |
Alkaloids | - | + | + |
Flavonoids | - | + | + |
Saponins | - | - | - |
Tannins & phenolic compound | - | + | + |
Proteins & amino acids | + | + | + |
Steroids &sterols | + | - | |
Glycosides | - | + | + |
Fixed oil | + | - | - |
(+) = indicates presence; (-) = indicates absence
TABLE 2: EFFECT OF MEDM AND GLIBENCLAMIDE IN OGTT OF CONTROL AND EXPERIMENTAL GROUPS OF RATS
Group | Treatment | Blood glucose level | |||
Fasting | After 30 mins | After 60 mins | After 90 mins | ||
I. | Glucose, 2gm/kg | 66.85 ± 2.67 | 146.32 ± 2.76 | 135.83 ± 2.62 | 123.46 ± 4.55 |
II. | MEDM 100mg/kg | 76.46 ± 3.85 | 122.83 ± 4.23* | 117.52±5.64* | 104.17 ± 3.65* |
III. | MEDM 200mg/kg | 71.33 ± 2.44 | 109.86 ± 3.84* | 98.83±3.768 | 87.54 ± 2.45* |
IV. | Glibenclamide, 3mg/kg | 68.16 ± 3.36 | 95.2.5 ± 3.42 | 83.16 ±3.18* | 78.84 ± 3.16* |
Values are given as mean ± S.E.M for groups of six animals each. Values are statistically significant at *p<0.05. Diabetic rats were compared with control rats. MEDM treated diabetic rats were compared with diabetic Glibenclamide treated diabetic rats were compared with diabetic control rats
FIG. : EFFECT OF MEDM AND GLIBENCLAMIDE IN OGTT OF CONTROL AND EXPERIMENTAL GROUPS OF RATS
TABLE 4: BODY WEIGHT CHANGES IN METHANOL EXTRACT OF DIGERA MURICATA AND GLIBENCLAMIDE ON CONTROL AND EXPERIMENTAL GROUPS OF RATS
Group | Treatment/Dose | Body weight (kg) Initial | Body weight (kg) Final |
I. | Normal Control rats + Vehicles only | 186.16±11.46 | 212.33±13.32 |
II. | Diabetic Control rats | 208.23±12* | 174.26±9.52* |
III. | Normal rats + EEAB(100 mg/kg) | 179.62±22.58* | 177.16±25.76* |
IV. | Diabetic group + MEDM(200 mg/kg ) | 212.80±9.67* | 214.62±9.28* |
V. | Diabetic rats+ Glibenclamide (3mg/kg) | 218.64±12.65* | 217.31±15.88* |
Values are given as mean ± S.E.M for groups of six animals each. Values are statistically significant at *p<0.01 Diabetic rats were compared with control rats. MEDM treated diabetic rats were compared with diabetic control rats Glibenclamide treated diabetic rats were compared with diabetic control rats
TABLE 5: CHANGES IN BLOOD GLUCOSE LEVEL
Group | Treatment | 0 day | 7 day | 14 days | 21 days |
I | Control | 100.76 ±5.13 | 96.98± 6.48 | 91.14 ±5.62 | 95.18 ± 3.65 |
II | Diabetic control | 281.65±14.42* | 293.12±21.22* | 325.56±16.28* | 344.83±17.68* |
III | Medm100 | 271.02± 3.74* | 269.32 ±8.21* | 272.82±11.80* | 270.48 15.02* |
IV | Medm200 | 278.49± 4.66* | 266.78±12.49* | 255.40 12.62* | 246.16±13.68* |
V | Std | 298.56 ±6.52* | 298.24 ±3.44* | 25.33 ±3.46 * | 210.31±2.36* |
Values are given as mean ± S.E.M for groups of six animals each. Values are statistically significant at *p<0.05. Diabetic rats were compared with control rats. MEDM treated diabetic rats were compared with diabetic control rats. Glibenclamide treated diabetic rats were compared with diabetic control rats
FIG. : CHANGES IN BLOOD GLUCOSE LEVEL
TABLE 7: EFFECT OF METHANOL EXTRACT OF DIGERA MURICATA AND GLIBENCLAMIDE ON PLASMA INSULIN, HbA1C OF CONTROL AND EXPERIMENTAL GROUPS OF RATS
Groups/Treatment/Dose | Insulin µU/ml | HbA1c % |
I. Normal Control rats | 31.8±1.58 | 3.70±.26 |
II. Diabetic Control rats | 17.83±1.58* | 6.42±.32* |
III. Normal rats + MEDM 100mg/kg | 19.16±0.76* | 5.03±0.45* |
IV. Diabetic rats + MEDM 200mg/kg | 24± 1.04* | 5.12± 0.32* |
V. Diabetic rats + Glibenclamide | 33.16 ±2.56* | 3.69± 0.28* |
Values are given as mean ± S.E.M for groups of six animals each. Values are statistically significant at *p<0.05. Diabetic rats were compared with control rats. MEDM treated diabetic rats were compared with diabetic control rats. Glibenclamide treated diabetic rats were compared with diabetic control rats
TABLE 8: EFFECT OF MEDM AND GLIBENCLAMIDE IN TOTAL CHOLESTEROL, TRIGLYCERIDES, HDL CHOLESTEROL, LDL CHOLESTEROL, VLDL CHOLESTEROL OF CONTROL AND EXPERIMENTAL GROUPS OF RATS
Group | Treatment | Total cholesterol (mg/dl) | HDL cholesterol(mg/dl) | Triglycerides(mg/dl) | LDL(mg/dl) | VLDL(mg/dl) |
I | Control | 98.68±4.34 | 33.35 ± 1.35 | 108.56 ±1.43 | 46.8 ± 1.56* | 16.4 ± 0.56* |
II | Diabetic control (alloxan) | 176.60 ±0.67* | 22.34 ± 0.67* | 171.5± 2.45* | 118.4 ± 1.04* | 33.4 ± 0.85* |
III | MEDM (100mg/kg) | 127.6 ± 1.05* | 28.45 ± 1.05* | 121.3 ± 1.93* | 73.6 ± 1.8* | 23.4 ± 0.09* |
IV | MEDM (200mg/kg) | 111.7± 2.57* | 34.10± 0.43* | 101.7 ± 3.76* | 56.8 ± 2.2* | 19.4 ± 1.30* |
V | Glibenclamide | 103.56± 3.638* | 39.21 ± 1.06* | 91.12 ± 0.86* | 44.6 ± 1.7* | 17.4 ± 0.32* |
Values are given as mean ± S.E.M for groups of six animals each. Values are statistically significant at *p<0.05. Diabetic rats were compared with control rats. MEDM treated diabetic rats were compared with diabetic Glibenclamide treated diabetic rats were compared with diabetic control rat
TABLE 9: EFFECT ON MEDM CHANGES IN ALP LEVEL
Group |
Treatment/dose | ALP U/L |
I | Normal control | 112.64 ± 2.51 |
II | Diabetic control | 178.49± 4.38* |
III | MEDM 100 | 153.14 ± 5.34* |
IV | MEDM 200 | 157.15 ±5.18* |
V | Glibenclamide | 123.14 ±2.18* |
Values are given as mean ± S.E.M for groups of six animals each. Values are statistically significant at *p<0.05. Diabetic rats were compared with control rats. MEDM treated diabetic rats were compared with diabetic Glibenclamide treated diabetic rats were compared with diabetic control rates
ACKNOWLEDGEMENT: This work is carried out at the Department of Pharmaceutical Chemistry, JKKMMRF College of Pharmacy, Komarapalayam, Namakkal (Dt), Tamil Nadu. Authors are highly thankful to the Secretary and the Principal for providing the facilities.
CONCLUSION: In present study indicates that Digera muricata leaves of methanolic extract exhibited significant Antidiabetic activity in alloxan induced rats and also parameters like blood glucose level, body weight ,lipid profile along with plasma insulin, HbA1c, ALP.
REFERENCE:
- Bhagwat P., Diabetes mellitus causes and treatment (Ayurvedic perspective), TheAntiseptic, 2006, 103(4), 221-222.
- Tiwari A. K., Wisdom of ayurveda in perceiving diabetes: enigma of therapeutic recognition, Current Science, 2005, 88(7), 1043-1051.
- Parrotta J A, Healing Plants of Peninsular India. CABI Publishing CAB International, New York, USA, 2001, 56.
- Pratima Mathad; Sundar S. Mety, Plant Biotechnology Laboratory, Department of Post-Graduate Studies and Research in Botany, Gulbarga University, Gulbarga, India. E-Journal of Chemistry (2010) 7(1) 275 -280
- Khan Muhammad Rashid; Ahmed Dawood Department of Biochemistry, international journal published for the British Industrial Biological Research Association (2009), 47(6).1393–9
- Khan, Muhammad R.; Rizvi, Wajiha; Khan, Gul N.; Khan, Rahmat A.; Shaheen, Saima. Department of Biochemistry, Islamabad, Pak. Journal of Ethnopharmacology (2009), 122(1), 91-99
- Khan, Muhammad Rashid; Ahmed, Dawood. Department of Biochemistry, Faculty of Biological Sciences, Quaid-i-Azam University, Islamabad, Pak. Food and Chemical Toxicology (2009), 47(6), 1393-1399
- OECD guidelines 423. Acute classic method.
- Surjit Singh M. Geetha P. Amudha and A Vijit Chakraborty Evalution of Anti-Diabetic Activity of Methanolic extract of Flacourtia Jangomas (Lour) in Streptozotocin -Induced Diabetic Rats International Journal of Pharma and Bio Sciences Vol I 2010
- Swapnadeep Parial et al Anti-Diabetic Activity of Ficus Retusa leaves Drug Invention Today , 20102(1) , 96-101
- Kumawat N. S., Chaudhari S. P., Wani N. S. Antidiabetic activity of ethanol extract of Colocasiaesculenta leaves in alloxan induced diabetic rats Vol.2, No.2, pp 1246-1249, April-June 2010
- Syed Mansoor Ahmed, Vrushabendra Swamy and VM Chandrashekara Anti-Diabetic Activity of Terminalia catappa Leaf Extracts in Alloxan-Induced Diabetic Rats Iranian journal of pharmacology & therapeutics 1735-2657/05/41-36-39
- N. Malpani, K.P Manjunath, Hasan Pasha. Sholapur, R.V. Anti-Diabetic Activity of Cassia fistula Linn Bark in Alloxan-Induced Diabetic Rats International Journal of Pharmaceutical Sciences Jan-April 2010 2(1):382-38
Article Information
28
1525-1529
546
1397
English
Ijpsr
G. Jagatha* and N. Senthilkumar
Department of Pharmaceutical Chemistry, JKKMMRF College of Pharmacy, Komarapalayam, Namakkal Dist., Tamil Nadu, India
08 March, 2011
28 March, 2011
28 May, 2011
http://dx.doi.org/10.13040/IJPSR.0975-8232.2(6).1525-29
01 June, 2011